Enzyme-linked immunosorbent assay for the specific detection of angiostatin-like plasminogen moieties in biological samples

Thrombosis Research

Volumn 102, Issue 1, 2001, Pages 53-59

  Lijnen, H R ^a   Bloemmen, F ^a   Vereecken, A ^b   Collen, D ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Riatol Laboratories   (Belgium)

Author keywords

Angiostatin; ELISA; Plasminogen

Indexed keywords

ANGIOSTATIN; EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MA 31E9; MONOCLONAL ANTIBODY MA 34D3; MONOCLONAL ANTIBODY MA 36E6; MONOCLONAL ANTIBODY MA 42B12; PLASMINOGEN; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; BODY FLUID; CANCER PATIENT; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; KRINGLE DOMAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; QUANTITATIVE ASSAY;

ANGIOSTATINS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; BODY FLUIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; NEOPLASMS; PEPTIDE FRAGMENTS; PLASMINOGEN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0035311991     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00217-1     Document Type: Article

References (30)

1. Structure of plasminogen
2. Molecular cloning and characterization of a full-length cDNA clone for human plasminogen
3. The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin
4. Characterization of human plasminogen: I. On the relationship between different molecular forms of plasminogen demonstrated in plasma and found in purified preparations
5. Characterization of human plasminogen: II. Separation and partial characterization of different molecular forms of human plasminogen
6. On the regulation and control of fibrinolysis
7. Mechanisms of plasminogen activation
8. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
9. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells
10. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer
11. Suppression of tumor growth with recombinant murine angiostatin
12. Suppression of tumor growth with recombinant murine angiostatin
13. Multiple forms of angiostatin induce apoptosis in endothelial cells
14. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD
15. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma
16. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin
17. Generation of angiostatin by reduction and proteolysis of plasmin. Catalysis by a plasmin reductase secreted by cultured cells
18. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9)
19. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3)
20. A monoclonal antibody specific for Lys-plasminogen. Application to the study of the activation pathways of plasminogen in vivo
21. Plasminogen: Purification from human plasma by affinity chromatography
22. The primary structure of human plasminogen: Isolation of two lysine-binding fragments and one "mini-plasminogen" (MW. 38,000) by elastase-catalyzed-specific limited proteolysis
23. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
24. Peroxidase-labeled antibody. A new method of conjugation
25. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system
26. Screening panels of monoclonal antibodies using phage-displayed antigen
27. Mechanisms of angiogenesis
28. Vascular development and disorders: Molecular analysis and pathogenic insights
29. Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest
30. Are angiostatin and endostatin cures for cancer?